Largest-Ever Psilocybin Study Reveals That It Significantly Helps Depression
Veriheal
JUNE 29, 2022
The study was conducted by COMPASS Pathways , a mental healthcare company that is “dedicated to accelerating patient access to evidence-based innovation in mental health.” 233 patients with TRD from 10 countries in North America and Europe received either 1 milligram, 10 milligrams, or 25 milligrams of the COMP360 psilocybin.
Let's personalize your content